Market Closed -
Toronto S.E.
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
3.53
CAD
|
+2.62%
|
|
+8.95%
|
+27.44%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,477
|
3,145
|
1,859
|
1,304
|
1,056
|
1,348
|
-
|
-
|
Enterprise Value (EV)
1 |
1,348
|
3,145
|
583.8
|
109.9
|
-113.6
|
161.5
|
157.5
|
1,348
|
P/E ratio
|
2.12
x
|
-33.6
x
|
-3.67
x
|
-5.62
x
|
-10.7
x
|
-57.5
x
|
-51.4
x
|
-10,697
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
104
x
|
53.8
x
|
19.7
x
|
10.4
x
|
8.92
x
|
9.83
x
|
8.23
x
|
7.25
x
|
EV / Revenue
|
40.1
x
|
53.8
x
|
6.18
x
|
0.88
x
|
-0.96
x
|
1.18
x
|
0.96
x
|
7.25
x
|
EV / EBITDA
|
-8.64
x
|
-17.1
x
|
-2.87
x
|
-1
x
|
1.31
x
|
-3.2
x
|
-4.14
x
|
-71.8
x
|
EV / FCF
|
-5.65
x
|
-14.2
x
|
-2.79
x
|
-0.87
x
|
1.85
x
|
-9.19
x
|
-8.8
x
|
-67.7
x
|
FCF Yield
|
-17.7%
|
-7.02%
|
-35.8%
|
-114%
|
54.2%
|
-10.9%
|
-11.4%
|
-1.48%
|
Price to Book
|
1.41
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
348,782
|
355,773
|
373,287
|
379,095
|
381,114
|
382,011
|
-
|
-
|
Reference price
2 |
9.970
|
8.840
|
4.980
|
3.440
|
2.770
|
3.530
|
3.530
|
3.530
|
Announcement Date
|
3/30/20
|
2/26/21
|
3/1/22
|
2/28/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
33.58
|
58.47
|
94.48
|
125
|
118.4
|
137.1
|
163.9
|
185.9
|
EBITDA
1 |
-156
|
-184.3
|
-203.7
|
-109.7
|
-86.52
|
-50.43
|
-38.03
|
-18.77
|
EBIT
1 |
-161.5
|
-224.4
|
-711.5
|
-169.9
|
-115.1
|
-82.11
|
-62.63
|
-34.61
|
Operating Margin
|
-480.91%
|
-383.88%
|
-753.13%
|
-135.84%
|
-97.2%
|
-59.88%
|
-38.2%
|
-18.61%
|
Earnings before Tax (EBT)
1 |
1,648
|
-91.7
|
-504.1
|
-183.1
|
-99.99
|
-21.6
|
-9.154
|
4.648
|
Net income
1 |
1,649
|
-91.53
|
-502.8
|
-229.6
|
-100.4
|
-17.26
|
-10.73
|
2.356
|
Net margin
|
4,911.6%
|
-156.55%
|
-532.15%
|
-183.6%
|
-84.78%
|
-12.59%
|
-6.54%
|
1.27%
|
EPS
2 |
4.708
|
-0.2628
|
-1.358
|
-0.6123
|
-0.2579
|
-0.0614
|
-0.0687
|
-0.000330
|
Free Cash Flow
1 |
-238.5
|
-220.8
|
-209.1
|
-125.7
|
-61.54
|
-17.57
|
-17.9
|
-19.93
|
FCF margin
|
-710.19%
|
-377.68%
|
-221.35%
|
-100.54%
|
-51.97%
|
-12.82%
|
-10.92%
|
-10.72%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/20
|
2/26/21
|
3/1/22
|
2/28/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
25.91
|
32.74
|
32.51
|
29.62
|
28.28
|
31.14
|
26.91
|
25.45
|
34.23
|
32.46
|
32.07
|
33.48
|
35.17
|
36.88
|
36.11
|
EBITDA
1 |
-59.38
|
-34.72
|
-24.55
|
-24.14
|
-29.32
|
-28.86
|
-22.39
|
-21.28
|
-20.95
|
-19.98
|
-14.2
|
-13.57
|
-12.24
|
-10.81
|
-13.29
|
EBIT
1 |
-71.62
|
-206.4
|
-46.82
|
-36.04
|
-41.9
|
-40.43
|
-29.38
|
-27.59
|
-30.04
|
-29.36
|
-23.2
|
-21.48
|
-19.39
|
-17.24
|
-
|
Operating Margin
|
-276.44%
|
-630.49%
|
-144.01%
|
-121.7%
|
-148.18%
|
-129.85%
|
-109.19%
|
-108.41%
|
-87.77%
|
-90.47%
|
-72.35%
|
-64.17%
|
-55.12%
|
-46.75%
|
-
|
Earnings before Tax (EBT)
1 |
98.29
|
-170.3
|
-41.94
|
-26.51
|
-46.99
|
-63.75
|
-27.64
|
-7.817
|
-3.924
|
-61.77
|
-7.12
|
-4.746
|
-1.762
|
-0.404
|
-
|
Net income
1 |
98.91
|
-169.6
|
-42.39
|
-25.97
|
-49.99
|
-107.3
|
-25.6
|
-11.19
|
-2.268
|
-60.79
|
-4.809
|
-3.028
|
-0.9226
|
0.6014
|
-
|
Net margin
|
381.81%
|
-518.07%
|
-130.38%
|
-87.68%
|
-176.8%
|
-344.67%
|
-95.16%
|
-43.95%
|
-6.63%
|
-187.29%
|
-14.99%
|
-9.04%
|
-2.62%
|
1.63%
|
-
|
EPS
2 |
0.2666
|
-0.4569
|
-0.1169
|
-0.0642
|
-0.1352
|
-0.2857
|
-0.0668
|
-0.0268
|
-
|
-0.1629
|
-0.0139
|
-0.0139
|
-0.006870
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/22
|
3/1/22
|
5/10/22
|
8/9/22
|
11/7/22
|
2/28/23
|
5/9/23
|
8/8/23
|
11/8/23
|
2/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,129
|
-
|
1,275
|
1,194
|
1,169
|
1,187
|
1,191
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-238
|
-221
|
-209
|
-126
|
-61.5
|
-17.6
|
-17.9
|
-19.9
|
ROE (net income / shareholders' equity)
|
66.7%
|
-4.23%
|
-26%
|
-13.6%
|
-2.29%
|
-1.95%
|
-4.7%
|
-3.3%
|
ROA (Net income/ Total Assets)
|
103%
|
-3.64%
|
-23.8%
|
-12.9%
|
-2.17%
|
-2.7%
|
-4.5%
|
-3.1%
|
Assets
1 |
1,608
|
2,513
|
2,109
|
1,776
|
4,621
|
639.4
|
238.3
|
-75.99
|
Book Value Per Share
|
7.090
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-0.5400
|
-0.5100
|
-0.5300
|
-0.3200
|
-0.1500
|
-0.0100
|
0.0500
|
-0.0400
|
Capex
1 |
55.1
|
39.9
|
14.1
|
4.7
|
3.4
|
5.17
|
4.69
|
5.53
|
Capex / Sales
|
164.01%
|
68.23%
|
14.97%
|
3.76%
|
2.87%
|
3.77%
|
2.86%
|
2.97%
|
Announcement Date
|
3/30/20
|
2/26/21
|
3/1/22
|
2/28/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
3.53
CAD Average target price
3.567
CAD Spread / Average Target +1.05% Consensus |
1st Jan change
|
Capi.
|
---|
| +27.44% | 985M | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | +0.09% | 1.65B | | -7.89% | 1.68B | | -12.97% | 1.53B | | +33.40% | 1.38B |
Alternative Medicine
|